On April 23, 2025, I attended the Goldman Sachs shareholder meeting as a representative of the National Center for Public Policy Research (I’m the Executive Director of its Free Enterprise Project). While there, I asked the following question of CEO David Solomon:
“Transgenderism is one of the most divisive issues today, including questions about whether a man can become a woman simply by saying so, whether children can be born in the wrong body, and so on. The divisiveness of that issue likely explains why many corporations have severed ties with the Human Rights Campaign's Corporate Equality Index (HRC’s CEI), which promotes transgenderism. Yet the HRC still lists Goldman as a Bronze Partner that scores 100% on the CEI. Arguably, a corporation must decide which side of the transgenderism issue it is on before deciding whether to continue with the HRC or not. Accordingly, my question is: Does Goldman support the proposition that a child can be born in the wrong body?”
Read Full Article »